Related Experiment Video
Updated: Nov 21, 2025
09:56
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
996
Chimeric RNAs in cancer
Xinrui Shi1, Sandeep Singh2, Emily Lin2
1Department of Biochemistry and Molecular Genetics, School of Medicine, University of Virginia, Charlottesville, VA, United States.
Advances in Clinical Chemistry
|January 17, 2021
Summary
Chimeric RNAs, hybrid transcripts from separate genes, are increasingly recognized beyond cancer. Novel non-canonical types offer potential as cancer biomarkers and therapeutic targets.
Area of Science:
- Molecular Biology
- Genomics
- Transcriptomics
Background:
- Chimeric RNAs are hybrid transcripts formed from two distinct genes.
- Traditionally linked to chromosomal rearrangements and oncogenesis, canonical chimeric RNAs have cancer-specific expression.
- Recent discoveries reveal non-canonical chimeric RNAs generated via intergenic splicing (trans-splicing or cis-SAGe) without genomic aberrations.
Purpose of the Study:
- To provide an overview of chimeric RNA categories and their expression in normal and cancerous tissues.
- To discuss bioinformatic and biological methods for identifying cancer-specific chimeric RNAs.
- To explore downstream methods for investigating their biogenesis, functions, and potential as cancer biomarkers.
Main Methods:
- Review of existing literature on chimeric RNA identification and characterization.
- Discussion of bioinformatic approaches for detecting chimeric RNAs.
- Outline of experimental techniques for studying chimeric RNA processing and function.
Main Results:
- Non-canonical chimeric RNAs are prevalent in normal physiology, with some exhibiting cancer-specific expression.
- These novel chimeric RNAs can possess functions independent of their parental genes, influencing cell growth and motility.
- The study highlights the potential of non-canonical chimeric RNAs as novel cancer diagnostic markers and therapeutic targets.
Conclusions:
- Chimeric RNAs represent a significant layer of the functional transcriptome.
- Understanding the biogenesis and function of cancer-specific chimeric RNAs is crucial for developing new cancer diagnostics and therapeutics.
- Non-canonical chimeric RNAs offer promising avenues for future cancer research and clinical applications.
Related Concept Videos
01:03Rous Sarcoma Virus (RSV) and Cancer
5.8K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.8K
01:51Mechanisms of Retrovirus-induced Cancers
5.9K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.9K
02:23Abnormal Proliferation
4.9K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
02:15Experimental RNAi
6.8K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.8K
02:28Leaky Scanning
5.4K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.4K
02:57Targeted Cancer Therapies
8.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.1K